GLOBUS MEDICAL INC (GMED) is a publicly traded Healthcare sector company. As of October 12, 2026, GMED trades at $76.70 with a market cap of $10.02B and a P/E ratio of 99.92. GMED moved +2.13% today. Year to date, GMED is -12.68%; over the trailing twelve months it is +34.77%. Its 52-week range spans $51.79 to $101.40. Analyst consensus is buy with an average price target of $98.75. Rallies surfaces GMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GMED insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $76.70 |
| Market Cap | $10.02B |
| P/E Ratio | 99.92 |
| EPS | $0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $101.40 |
| 52-Week Low | $51.79 |
| Volume | 892.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.52B |
| Net Income | $102.98M |
| Gross Margin | 58.90% |
13 analysts cover GMED: 0 strong buy, 9 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $98.75.